1.61 (-%)
As of Nov 21, 2024
Source:
Pmv Pharmaceuticals, Inc. is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53. p53 is a well-defined tumor suppressor protein known as the “guardian of the genome,” and normal, or wild-type, p53 has the ability to eliminate cancer cells.
Country | United States |
Headquarters | princeton, new jersey |
Phone Number | (609) 642-6664 |
Industry | manufacturing |
CEO | David H. Mack |
Website | pmvpharma.com |